Published on 15 Mar 2023 on Zacks via Yahoo Finance

Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know

Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this biotechnology company have returned -13.9%, compared to the Zacks S&P 500 composite's -5.1% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Moderna falls in, has lost 4.9%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.